Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
adjuvant
Biotech
Clover's COVID-19 vaccine tames delta in pivotal study
The adjuvanted protein vaccine held up against a range of variants in a phase 2/3 trial, teeing Clover up to seek approval this year.
Nick Paul Taylor
Sep 22, 2021 8:55am
Sanofi nets global phase 3 partners for breast cancer hopeful
Jun 4, 2021 1:00am
Medicago, GSK post data on plant-derived COVID-19 vaccine
May 18, 2021 5:21am
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Dec 4, 2020 8:25am
GlaxoSmithKline pens COVID-19 vaccine pact with Medicago
Jul 7, 2020 8:55am
Using GSK, Dynavax tech, Clover kick-starts COVID-19 vax trial
Jun 19, 2020 5:48am
